Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 2 Seizures 1 Liver Cirrhosis 1 Lennox Gastaut Syndrome 1 Epilepsies, Myoclonic 1 Behavior 1

Interventions

Riluzole 1 Cannabidiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Behavior × Cannabidiol × Clear all

NCT05864846 2026-04-27

EpiCom

Jazz Pharmaceuticals

Phase 4 Completed

Behavior, Seizures, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡